Emergent Biosolutions Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Emergent Biosolutions Inc. on February 14, 2018, reporting events that occurred on February 13, 2018. The filing details actions taken by the Compensation Committee of the Board of Directors regarding the compensation of Named Executive Officers (NEOs).
Key Financial Metrics
The filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive compensation adjustments.
Material Changes and Compensation Details
The Compensation Committee approved the following compensation adjustments effective for the 2017 and 2018 periods:
- 2017 Cash Bonuses:
- Daniel J. Abdun-Nabi (CEO): $806,208.00
- Robert G. Kramer, Sr. (CFO): $362,254.46
- Adam R. Havey (EVP, Biodefense): $264,176.64
- Fuad El-Hibri (Executive Chairman): Not bonus eligible
- 2018 Base Salaries and Target Bonuses (Effective Jan 1, 2018):
- Fuad El-Hibri: $1,023,339.20 salary; 0% target bonus
- Daniel J. Abdun-Nabi: $814,112.00 salary; 85% target bonus
- Robert G. Kramer, Sr.: $518,232.00 salary; 60% target bonus
- Adam R. Havey: $470,017.60 salary; 55% target bonus
- 2018 Equity Awards (Scheduled for Feb 27, 2018):
- Fuad El-Hibri ($1,915,000), Daniel J. Abdun-Nabi ($2,655,000), Robert G. Kramer, Sr. ($1,175,000), Adam R. Havey ($1,000,000).
- 50% Stock Options, 25% Time-based Restricted Stock Units (RSUs), 25% Performance-Based Stock Units (PSUs).
- 50% Stock Options, 50% Time-based RSUs.
- Vesting is based on net income as a percentage of total revenue for the 2020 fiscal year. Payout ranges from 50% (minimum) to 150% (maximum) of the target share count.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of general business risks. The primary contingency noted is the vesting of performance-based stock units, which is contingent upon achieving specific net income margins in the 2020 fiscal year as certified by the Committee.
Key Facts for Investor Verification
- Verify the total cash bonus payout of approximately $1.43 million to three NEOs for 2017 performance.
- Confirm the 2018 salary increases and target bonus percentages for the executive team.
- Review the specific terms of the 2018-2020 Performance-Based Stock Unit Award Agreement (Exhibit 10) to understand the exact net income margin thresholds required for PSU vesting.
- Note that the equity awards described are scheduled to be granted on February 27, 2018, not immediately upon the filing date.